Kazuma Kobayashi

Years Active: 2021-2022
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Toshikazu Moriwaki, Tomohiro Nishina, Yoshinori Sakai, Yoshiyuki Yamamoto, Mitsuo Shimada, Hiroyasu Ishida, Kenji Amagai, Mikio Sato, Shinji Endo, Yuji Negoro, Hidekazu Kuramochi, Tadamichi Denda, Yukimasa Hatachi, Kazuto Ikezawa, Go Nakajima, Yoshiaki Bando, Akihito Tsuji, Yuji Yamamoto, Masamitsu Morimoto, Kazuma Kobayashi, Ichinosuke Hyodo
Impact of chronological age on efficacy and safety of fluoropyrimidine plus bevacizumab in older non-frail patients with metastatic colorectal cancer: a combined analysis of individual data from two phase II studies of patients aged >75 years. Japanese journal of clinical oncology 52 (7) (2022)
Kazuma Kobayashi, Kengo Kanetaka, Akira Yoneda, Shinichiro Kobayashi, Yasuhiro Maruya, Yuriko Isagawa, Tomoko Yoshimoto, Kazushige Migita, Yuta Kawaguchi, Sayaka Kuba, Michi Morita, Satomi Okada, Taiichiro Kosaka, Shun Yamaguchi, Yusuke Inoue, Tomohiko Adachi, Masaaki Hidaka, Yasuhiro Torashima, Shinichiro Ito, Mitsuhisa Takatsuki, Susumu Eguchi
Downstaging and Histological Effects Might Be Reliable Predictors of the Efficacy of DOC+CDDP+5-FU (DCF) as Neoadjuvant Therapy for Stage III or Borderline Resectable Esophageal Cancer: a Single Institute Experience. Journal of gastrointestinal cancer 52 (2) (2021)

Kazuma Kobayashi.css-eqlu8i{font-size:small;padding-left:4px;}